NCT04119024 2026-03-17Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsStanford UniversityPhase 1 Recruiting18 enrolled
NCT01659151 2026-02-20Vemurafenib With Lymphodepletion Plus Adoptive Cell Transfer & High Dose IL-2 Metastatic MelanomaH. Lee Moffitt Cancer Center and Research InstitutePhase 2 Completed17 enrolled 11 charts
NCT07361133 2026-01-22Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell CancerNational Cancer Institute, EgyptPhase 2 Not yet recruiting120 enrolled
NCT06626256 2025-12-24STIL101 for Injection for the Treatment of Locally Advanced, Metastatic or Unresectable Pancreatic Cancer, Colorectal Cancer, Renal Cell Cancer, Cervical Cancer and MelanomaCity of Hope Medical CenterPhase 1 Withdrawn